Form 8-K Benitec Biopharma Inc. For: Sep 15 Sep 20, 2021 08:16AM http://archive.fast-edgar.com/20210920/AP2Z462EZZ2R6ZZU22ZQ2ZYQLR99ZZ22ZI36 Filed on: September 20, 2021
Form PRE 14C PhoneBrasil Internationa For: Sep 17 Sep 20, 2021 08:13AM

 

 

PRELIMINARY INFORMATION STATEMENT

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14C

 

Information Statement Pursuant to Section 14(c) and 14(f)

of the Securities Exchange Act of 1934

and

Rules 14c and 14f-1thereunder

 

Check the appropriate box:

 

☒ Preliminary Information Statement     ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ... (continue reading...)
Form 8-K LINKBANCORP, Inc. For: Sep 17 Sep 20, 2021 08:13AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 17, 2021

 

 

LINKBANCORP, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Pennsylvania   333-255908   82-5130531 (State or Other Jurisdictionof Incorporation)   (CommissionFile... (continue reading...)
Form 10-Q Jialijia Group Corp Ltd For: Jun 30 Sep 20, 2021 08:12AM

Exhibit 31.1

 

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Na Jin, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Jialijia Group Corporation Limited;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading... (continue reading...)


Form 8-K Mirati Therapeutics, For: Sep 20 Sep 20, 2021 08:11AM

Exhibit 99.1

 

Mirati Therapeutics Appoints David Meek as Chief Executive Officer

Charles M. Baum, M.D., Ph.D to Continue in New Role of President, Founder and Head of Research and Development

SAN DIEGO – September 20, 2021 – Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of David Meek as Chief Executive Officer (CEO), effective immediately. Mr. Meek will also join the Company’s Board... (continue reading...)


More SEC Filings

View Older Stories

Sep 20, 2021 08:09AM Form D BC Partners Electron
Sep 20, 2021 08:07AM Form 8-K Phathom Pharmaceuticals, For: Sep 17
Sep 20, 2021 08:06AM Form DEFA14A GigCapital4, Inc.
Sep 20, 2021 08:06AM Form 6-K Eros STX Global Corp For: Sep 20
Sep 20, 2021 08:05AM Form SC 13D/A APi Group Corp Filed by: FRANKLIN MARTIN E
Sep 20, 2021 08:03AM Form 8-K PEDEVCO CORP For: Sep 20
Sep 20, 2021 08:03AM Form 8-K Benitec Biopharma Inc. For: Sep 20
Sep 20, 2021 08:03AM Form 8-K SYNLOGIC, INC. For: Sep 20
Sep 20, 2021 08:03AM Form 6-K Ambow Education Holding For: Jun 30
Sep 20, 2021 08:01AM Form 10-K Benitec Biopharma Inc. For: Jun 30
Sep 20, 2021 08:01AM Form 8-K MIDDLEFIELD BANC CORP For: Sep 20
Sep 20, 2021 08:01AM Form SC 13D/A RING ENERGY, INC. Filed by: KUKES SIMON G
Sep 20, 2021 08:01AM Form DEFA14A GigCapital4, Inc.
Sep 20, 2021 08:01AM Form 4 J.Jill, Inc. For: Sep 17 Filed by: Spofford Claire
Sep 20, 2021 08:00AM Form 8-K SELECTA BIOSCIENCES INC For: Sep 20
Sep 20, 2021 08:00AM Form 4 Summit Midstream Partner For: Sep 16 Filed by: Deneke J Heath
Sep 20, 2021 08:00AM Form 6-K Cognyte Software Ltd. For: Jul 31
Sep 20, 2021 07:59AM Form 6-K PLDT Inc. For: Sep 20
Sep 20, 2021 07:54AM Form 8-K TRAQIQ, INC. For: Sep 17
Sep 20, 2021 07:48AM Form 6-K Medigus Ltd. For: Jun 30
Sep 20, 2021 07:45AM Form 8-K Teladoc Health, Inc. For: Sep 17
Sep 20, 2021 07:42AM Form 425 Athena Technology Acquis Filed by: Athena Technology Acquisition Corp.
Sep 20, 2021 07:37AM Form 1-U True Leaf Brands Inc. For: Sep 20
Sep 20, 2021 07:34AM Form D/A RF Parent, Inc.
Sep 20, 2021 07:31AM Form 25 WASHINGTON PRIME GROUP
Sep 20, 2021 07:31AM Form 25 WASHINGTON PRIME GROUP
Sep 20, 2021 07:30AM Form 25 WASHINGTON PRIME GROUP
Sep 20, 2021 07:21AM Form 425 Live Oak Acquisition Filed by: Live Oak Acquisition Corp II
Sep 20, 2021 07:20AM Form 425 Cartesian Growth Corp Filed by: Cartesian Growth Corp
Sep 20, 2021 07:17AM Form 8-K Cartesian Growth Corp For: Sep 20
Sep 20, 2021 07:16AM Form 8-K Live Oak Acquisition For: Sep 20
Sep 20, 2021 07:15AM Form 8-K Weatherford Internationa For: Sep 20
Sep 20, 2021 07:14AM Form 20-F/A Gol Intelligent Airlines For: Dec 31
Sep 20, 2021 07:12AM Form D Spring Valley Prospect
Sep 20, 2021 07:12AM Form 8-K COMPASS MINERALS INTERNA For: Sep 20
Sep 20, 2021 07:07AM Form 20FR12B Getnet Adquirencia E
Sep 20, 2021 07:07AM Form 8-K Target Hospitality Corp. For: Sep 20
Sep 20, 2021 07:06AM Form 8-K BIOCRYST PHARMACEUTICALS For: Sep 15
Sep 20, 2021 07:05AM Form 8-K Matinas BioPharma Holdin For: Sep 17
Sep 20, 2021 07:03AM Form 8-K Anterix Inc. For: Sep 20
Sep 20, 2021 07:03AM Form DEFA14A Astrea Acquisition Corp.
Sep 20, 2021 07:02AM Form 8-K WINDTREE THERAPEUTICS For: Sep 20
Sep 20, 2021 07:01AM Form 425 Trident Acquisitions Filed by: Trident Acquisitions Corp.
Sep 20, 2021 07:01AM Form 3 OOMA INC For: Sep 07 Filed by: Hamamatsu Shigeyuki
Sep 20, 2021 07:01AM Form 8-K Astrea Acquisition Corp. For: Sep 17
Sep 20, 2021 07:01AM Form DEF 14C NEWTOWN LANE MARKETING For: Sep 20
Sep 20, 2021 07:01AM Form 8-K ORASURE TECHNOLOGIES For: Sep 14
Sep 20, 2021 07:01AM Form 425 Trident Acquisitions Filed by: Trident Acquisitions Corp.
Sep 20, 2021 06:59AM Form 6-K NOVO NORDISK A S For: Sep 20
Sep 20, 2021 06:59AM Form 425 Great Western Bancorp, Filed by: Great Western Bancorp, Inc.
View Older Stories